Document is current
Any future updates will be listed below
-
Authors
Denkert, Carsten https://orcid.org/0000-0002-2249-0982
Budczies, Jan
Regan, Meredith M.
Loibl, Sibylle
Dell’Orto, Patrizia
von Minckwitz, Gunter
Mastropasqua, Mauro G.
Solbach, Christine
Thürlimann, Beat
Mehta, Keyur
Blohmer, Jens-Uwe
Colleoni, Marco
Müller, Volkmar
Klauschen, Frederick
Ataseven, Beyhan
Engels, Knut
Kammler, Roswitha
Pfitzner, Berit M.
Dietel, Manfred
Fasching, Peter A.
Viale, Giuseppe
-
Funding
Funding for this research was provided by:
Deutsche Krebshilfe (TransLuminal B)
- License Information
-
More Information
Article History
Received: 14 December 2018
Accepted: 18 December 2018
First Online: 7 May 2019
Compliance with ethical standards
:
: Author C. Denkert has been cofounder and shareholder of Sividon Diagnostics and co-inventor of the vmScope digital image analysis system; he was an advisor/consultant for Teva, Roche, AstraZeneca, Celgene, Pfizer, Novartis, Daiichi and MSD. Author B. Thürlimann is an advisor/consultant of Pfizer, Amgen, Genomic Health Inc, Eli Lilly and reports stock ownership of Novartis and Roche. Author M. Dietel is an advisor/consultant of provitro AG. Author B. Ataseven is an advisor/consultant of Roche and Amgen and reports funding form Tesaro and Astra Zeneca. All other authors report no conflicts of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This article does not contain any studies with animals performed by any of the authors.
: Informed consent was obtained from all individual participants included in the clinical trials.
